1932
0
  1. Home
  2. A-Z Publications
  3. Annual Review of Clinical Psychology
  4. Volume 16, 2020
  5. Article

Annual Review of Clinical Psychology

Volume 16, 2020

Stress Allostasis in Substance Use Disorders: Promise, Progress, and Emerging Priorities in Clinical Research

Abstract

Clinicians and researchers alike have long believed that stressors play a pivotal etiologic role in risk, maintenance, and/or relapse of alcohol and other substance use disorders (SUDs). Numerous seminal and contemporary theories on SUD etiology posit that stressors may motivate drug use and that individuals who use drugs chronically may display altered responses to stressors. We use foundational basic stress biology research as a lens through which to evaluate critically the available evidence to support these key stress–SUD theses in humans. Additionally, we examine the field's success to date in targeting stressors and stress allostasis in treatments for SUDs. We conclude with our recommendations for how best to advance our understanding of the relationship between stressors and drug use, and we discuss clinical implications for treatment development.

Keyword(s): addiction, allostasis, stress, substance use disorders, treatment
Loading

Article metrics loading...

/content/journals/10.1146/annurev-clinpsy-102419-125016
2020-05-07
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/clinpsy/16/1/annurev-clinpsy-102419-125016.html?itemId=/content/journals/10.1146/annurev-clinpsy-102419-125016&mimeType=html&fmt=ahah

Literature Cited

  1. al'Absi M, Nakajima M, Grabowski J 2013. Stress response dysregulation and stress-induced analgesia in nicotine dependent men and women. Biol. Psychol. 93:11–8 https://doi.org/10.1016/j.biopsycho.2012.12.007
    [Crossref] [Google Scholar]
  2. Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP 2005. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J. Subst. Abuse Treat. 28:4321–29 https://doi.org/10.1016/j.jsat.2005.02.007
    [Crossref] [Google Scholar]
  3. Armeli S, Dehart T, Tennen H, Todd M, Affleck G 2007. Daily interpersonal stress and the stressor-vulnerability model of alcohol use. J. Soc. Clin. Psychol. 26:8896–921 https://doi.org/10.1521/jscp.2007.26.8.896
    [Crossref] [Google Scholar]
  4. Arnsten AFT. 2009. Stress signalling pathways that impair prefrontal cortex structure and function. Nat. Rev. Neurosci. 10:6410–22 https://doi.org/1 0.1038/nrn2648
    [Crossref] [Google Scholar]
  5. Back SE, Hartwell K, DeSantis SM, Saladin M, McRae-Clark AL et al. 2010. Reactivity to laboratory stress provocation predicts relapse to cocaine. Drug Alcohol Depend 106:121–27 https://doi.org/10.1016/j.drugalcdep.2009.07.016
    [Crossref] [Google Scholar]
  6. Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC 2004. Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol. Rev. 111:133–51
     [Google Scholar]
  7. Binneman B, Feltner D, Kolluri S, Shi Y, Qiu R, Stiger T 2008. A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression. Am. J. Psychiatry 165:5617–20
     [Google Scholar]
  8. Bisaga A, Aharonovich E, Garawi F, Levin FR, Rubin E et al. 2006. A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug Alcohol Depend 81:3267–74 https://doi.org/10.1016/j.drugalcdep.2005.07.009
    [Crossref] [Google Scholar]
  9. Bowen S, Witkiewitz K, Clifasefi SL, Grow J, Chawla N et al. 2014. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry 71:5547–56 https://doi.org/10.1001/jamapsychiatry.2013.4546
    [Crossref] [Google Scholar]
  10. Bradford DE, Curtin JJ, Piper ME 2015. Anticipation of smoking sufficiently dampens stress reactivity in nicotine-deprived smokers. J. Abnorm. Psychol. 124:1128–36 https://doi.org/10.1037/abn0000007
    [Crossref] [Google Scholar]
  11. Bradford DE, Kaye JT, Curtin JJ 2014. Not just noise: individual differences in general startle reactivity predict startle response to uncertain and certain threat. Psychophysiology 51:5407–11 https://doi.org/10.1111/psyp.12193
    [Crossref] [Google Scholar]
  12. Bradford DE, Motschman CA, Starr MJ, Curtin JJ 2017. Alcohol's effects on emotionally motivated attention, defensive reactivity and subjective anxiety during uncertain threats. Soc. Cogn. Affect. Neurosci. 12:111823–32
     [Google Scholar]
  13. Bradford DE, Shapiro BL, Curtin JJ 2013. How bad could it be? Alcohol dampens stress responses to threat of uncertain intensity. Psychol. Sci. 24:122541–49 https://doi.org/10.1177/0956797613499923
    [Crossref] [Google Scholar]
  14. Breese GR, Overstreet DH, Knapp DJ 2005. Conceptual framework for the etiology of alcoholism: a “kindling”/stress hypothesis. Psychopharmacology 178:367–80 https://doi.org/10.1007/s00213-004-2016-2
    [Crossref] [Google Scholar]
  15. Brewer JA, Mallik S, Babuscio TA, Nich C, Johnson HE et al. 2011. Mindfulness training for smoking cessation: results from a randomized controlled trial. Drug Alcohol Depend 119:1–272–80 https://doi.org/10.1016/j.drugalcdep.2011.05.027
    [Crossref] [Google Scholar]
  16. Burchfield SR. 1979. The stress response: a new perspective. Psychosom. Med. 41:8661–72
     [Google Scholar]
  17. Butelman ER, Kreek MJ. 2017. Medications for substance use disorders (SUD): emerging approaches. Expert Opin. Emerg. Drugs 22:4301–15 https://doi.org/10.1080/14728214.2017.1395855
    [Crossref] [Google Scholar]
  18. Button KS, Ioannidis JPA, Mokrysz C, Nosek BA, Flint J et al. 2013. Power failure: why small sample size undermines the reliability of neuroscience. Nat. Rev. Neurosci. 14:5365–76 https://doi.org/10.1038/nrn3475
    [Crossref] [Google Scholar]
  19. Cannon WB. 1915. Bodily Changes in Pain, Hunger, Fear and Rage: An Account of Recent Researches into the Function of Emotional Excitement New York: D. Appleton http://archive.org/details/cu31924022542470
  20. Cannon WB. 1932. The Wisdom of the Body New York: W.W. Norton
  21. Carroll KM. 1998. A cognitive-behavioral approach: treating cocaine addiction NIH publ. 98-4308, US Dep. Health Hum. Serv., Natl. Inst. Health Rockville, MD:
  22. Chattarji S, Tomar A, Suvrathan A, Ghosh S, Rahman MM 2015. Neighborhood matters: divergent patterns of stress-induced plasticity across the brain. Nat. Neurosci. 18:101364–75 https://doi.org/10.1038/nn.4115
    [Crossref] [Google Scholar]
  23. Cinciripini PM, Robinson JD, Carter BL, Lam C, Wu X et al. 2006. The effects of smoking deprivation and nicotine administration on emotional reactivity. Nicotine Tob. Res. 8:3379–92 https://doi.org/10.1080/14622200600670272
    [Crossref] [Google Scholar]
  24. Coffey SF, Saladin ME, Drobes DJ, Brady KT, Dansky BS, Kilpatrick DG 2002. Trauma and substance cue reactivity in individuals with comorbid posttraumatic stress disorder and cocaine or alcohol dependence. Drug Alcohol Depend 65:2115–27 https://doi.org/10.1016/S0376-8716(01)00157-0
    [Crossref] [Google Scholar]
  25. Coffey SF, Schumacher JA, Stasiewicz PR, Henslee AM, Baillie LE, Landy N 2010. Craving and physiological reactivity to trauma and alcohol cues in posttraumatic stress disorder and alcohol dependence. Exp. Clin. Psychopharmacol. 18:4340–49 https://doi.org/10.1037/a0019790
    [Crossref] [Google Scholar]
  26. Coffey SF, Stasiewicz PR, Hughes PM, Brimo ML 2006. Trauma-focused imaginal exposure for individuals with comorbid posttraumatic stress disorder and alcohol dependence: revealing mechanisms of alcohol craving in a cue reactivity paradigm. Psychol. Addict. Behav. 20:4425–35
     [Google Scholar]
  27. Cohen S, Murphy MLM, Prather AA 2019. Ten surprising facts about stressful life events and disease risk. Annu. Rev. Psychol. 70:577–97 https://doi.org/10.1146/annurev-psych-010418-102857 Critically reviews what we know, do not know, and need to learn about stress and health.
     [Crossref] [Google Scholar]
  28. Constantinou N, Morgan CJA, Battistella S, O'Ryan D, Davis P, Curran HV 2010. Attentional bias, inhibitory control and acute stress in current and former opiate addicts. Drug Alcohol Depend 109:1220–25 https://doi.org/10.1016/j.drugalcdep.2010.01.012
    [Crossref] [Google Scholar]
  29. Cooney NL, Litt MD, Morse PA, Bauer LO, Gaupp L 1997. Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men. J. Abnorm. Psychol. 106:2243–50 https://doi.org/10.1037/0021-843X.106.2.243
    [Crossref] [Google Scholar]
  30. Coric V, Feldman HH, Oren DA, Shekhar A, Pultz J et al. 2010. Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder. Depress. Anxiety 27:5417–25 https://doi.org/10.1002/da.20695
    [Crossref] [Google Scholar]
  31. Cronk NJ, Piasecki TM. 2010. Contextual and subjective antecedents of smoking in a college student sample. Nicotine Tob. Res. 12:10997–1004 https://doi.org/10.1093/ntr/ntq136
    [Crossref] [Google Scholar]
  32. Curtin JJ, McCarthy DE, Piper ME, Baker TB 2006. Implicit and explicit drug motivational processes: a model of boundary conditions. Handbook of Implicit Cognition and Addiction RW Wiers, AW Stacy 233–50 Thousand Oaks, CA: Sage
     [Google Scholar]
  33. Curtin JJ, Zhu X, Gustafson D, Alagoz O 2015. NIAAA R01: dynamic, real-time prediction of alcohol use lapse using mHealth technologies. Open Sci. Framew. (OSF). https://osf.io/szjue/
    [Google Scholar]
  34. Davidson C, Neighbors C, Hall G, Hogue A, Cho R et al. 2014. Association of housing first implementation and key outcomes among homeless persons with problematic substance use. Psychiatr. Serv. 65:111318–24 https://doi.org/10.1176/appi.ps.201300195
    [Crossref] [Google Scholar]
  35. Davis M, Walker DL, Miles L, Grillon C 2010. Phasic versus sustained fear in rats and humans: role of the extended amygdala in fear versus anxiety. Neuropsychopharmacol. Rev. 35:1105–35Suggests distinct mediating pathways in the extended amygdala as a function of stressor characteristics.
     [Google Scholar]
  36. de Guglielmo G, Cippitelli A, Somaini L, Gerra G, Li H et al. 2013. Pregabalin reduces cocaine self-administration and relapse to cocaine seeking in the rat. Addict. Biol. 18:4644–53 https://doi.org/10.1111/j.1369-1600.2012.00468.x
    [Crossref] [Google Scholar]
  37. de Wit H, Epstein DH, Preston KL 2018. Does human language limit translatability of clinical and preclinical addiction research. Neuropsychopharmacology 43:101985–88 https://doi.org/10.1038/s41386-018-0095-8
    [Crossref] [Google Scholar]
  38. Dimoff JD, Sayette MA. 2017. The case for investigating social context in laboratory studies of smoking. Addiction 112:3388–95 https://doi.org/10.1111/add.13503
    [Crossref] [Google Scholar]
  39. Ditre JW, Zale EL, LaRowe LR 2019. A reciprocal model of pain and substance use: transdiagnostic considerations, clinical implications, and future directions. Annu. Rev. Clin. Psychol. 15:503–28 https://doi.org/10.1146/annurev-clinpsy-050718-095440
    [Crossref] [Google Scholar]
  40. Dunlop BW, Binder EB, Iosifescu D, Mathew SJ, Neylan TC et al. 2017. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol. Psychiatry 82:12866–74 https://doi.org/10.1016/j.biopsych.2017.06.024
    [Crossref] [Google Scholar]
  41. Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW 2008. A meta-analytic review of psychosocial interventions for substance use disorders. Am. J. Psychiatry 165:2179–87 https://doi.org/10.1176/appi.ajp.2007.06111851
    [Crossref] [Google Scholar]
  42. Evans BE, Greaves-Lord K, Euser AS, Tulen JHM, Franken IHA, Huizink AC 2012. Alcohol and tobacco use and heart rate reactivity to a psychosocial stressor in an adolescent population. Drug Alcohol Depend 126:3296–303 https://doi.org/10.1016/j.drugalcdep.2012.05.031
    [Crossref] [Google Scholar]
  43. Fox AS, Shackman AJ. 2019. The central extended amygdala in fear and anxiety: closing the gap between mechanistic and neuroimaging research. Neurosci. Lett. 693:58–67 https://doi.org/10.1016/j.neulet.2017.11.056
    [Crossref] [Google Scholar]
  44. Fox HC, Anderson GM, Tuit K, Hansen J, Kimmerling A et al. 2012a. Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings. Alcohol Clin. Exp. Res. 36:2351–60 https://doi.org/10.1111/j.1530-0277.2011.01628.x
    [Crossref] [Google Scholar]
  45. Fox HC, Hong K-IA, Siedlarz K, Sinha R 2008. Enhanced sensitivity to stress and drug/alcohol craving in abstinent cocaine-dependent individuals compared to social drinkers. Neuropsychopharmacology 33:4796–805 https://doi.org/10.1038/sj.npp.1301470
    [Crossref] [Google Scholar]
  46. Fox HC, Seo D, Tuit K, Hansen J, Kimmerling A et al. 2012b. Guanfacine effects on stress, drug craving and prefrontal activation in cocaine dependent individuals: preliminary findings. J. Psychopharmacol. 26:7958–72 https://doi.org/10.1177/0269881111430746
    [Crossref] [Google Scholar]
  47. Furnari M, Epstein DH, Phillips KA, Jobes ML, Kowalczyk WJ et al. 2015. Some of the people, some of the time: field evidence for associations and dissociations between stress and drug use. Psychopharmacology 232:193529–37 https://doi.org/10.1007/s00213-015-3998-7
    [Crossref] [Google Scholar]
  48. Gilpin NW, Weiner JL. 2017. Neurobiology of comorbid post-traumatic stress disorder and alcohol-use disorder. Genes Brain Behav 16:115–43 https://doi.org/10.1111/gbb.12349
    [Crossref] [Google Scholar]
  49. Ginty AT, Jones A, Carroll D, Roseboom TJ, Phillips AC et al. 2014. Neuroendocrine and cardiovascular reactions to acute psychological stress are attenuated in smokers. Psychoneuroendocrinology 48:87–97 https://doi.org/10.1016/j.psyneuen.2014.05.023
    [Crossref] [Google Scholar]
  50. Goldberg SB, Tucker RP, Greene PA, Davidson RJ, Wampold BE et al. 2018. Mindfulness-based interventions for psychiatric disorders: a systematic review and meta-analysis. Clin. Psychol. Rev. 59:52–60 https://doi.org/10.1016/j.cpr.2017.10.011
    [Crossref] [Google Scholar]
  51. González G, Desai R, Sofuoglu M, Poling J, Oliveto A et al. 2007. Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug Alcohol Depend 87:11–9 https://doi.org/10.1016/j.drugalcdep.2006.07.003
    [Crossref] [Google Scholar]
  52. Gorka SM, Kreutzer KA, Petrey KM, Radoman M, Phan KL 2019. Behavioral and neural sensitivity to uncertain threat in individuals with alcohol use disorder: associations with drinking behaviors and motives. Addict. Biol. In press. https://doi.org/10.1111/adb.12774
    [Crossref] [Google Scholar]
  53. Gorka SM, Lieberman L, Phan KL, Shankman SA 2016. Association between problematic alcohol use and reactivity to uncertain threat in two independent samples. Drug Alcohol Depend 164:89–96 https://doi.org/10.1016/j.drugalcdep.2016.04.034
    [Crossref] [Google Scholar]
  54. Gorka SM, Shankman SA. 2017. Preliminary evidence that reactivity to uncertain threat is an endophenotype for alcohol use disorder. Drug Alcohol Depend 180:265–71 https://doi.org/10.1016/j.drugalcdep.2017.08.023
    [Crossref] [Google Scholar]
  55. Greenwald MK. 2018. Anti-stress neuropharmacological mechanisms and targets for addiction treatment: a translational framework. Neurobiol. Stress 9:84–104 https://doi.org/10.1016/j.ynstr.2018.08.003
    [Crossref] [Google Scholar]
  56. Grillon C, Avenevoli S, Daurignac E, Merikangas KR 2007. Fear-potentiated startle to threat, and prepulse inhibition among young adult nonsmokers, abstinent smokers, and nonabstinent smokers. Biol. Psychiatry 62:101155–61 https://doi.org/10.1016/j.biopsych.2006.12.027
    [Crossref] [Google Scholar]
  57. Gustafson DH, McTavish FM, Chih M-Y, Atwood AK, Johnson RA et al. 2014. A smartphone application to support recovery from alcoholism: a randomized clinical trial. JAMA Psychiatry 71:5566–72 https://doi.org/10.1001/jamapsychiatry.2013.4642
    [Crossref] [Google Scholar]
  58. Hart CL, Haney M, Vosburg SK, Rubin E, Foltin RW 2007. Gabapentin does not reduce smoked cocaine self-administration: employment of a novel self-administration procedure. Behav. Pharmacol. 18:171–75 https://doi.org/10.1097/FBP.0b013e328014139d
    [Crossref] [Google Scholar]
  59. Heckman BW, Carpenter MJ, Correa JB, Wray JM, Saladin ME et al. 2015. Effects of experimental negative affect manipulations on ad libitum smoking: a meta-analysis. Addiction 110:5751–60 https://doi.org/10.1111/add.12866
    [Crossref] [Google Scholar]
  60. Heckman BW, Kovacs MA, Marquinez NS, Meltzer LR, Tsambarlis ME et al. 2013. Influence of affective manipulations on cigarette craving: a meta-analysis. Addiction 108:122068–78 https://doi.org/10.1111/add.12284
    [Crossref] [Google Scholar]
  61. Hefner KR, Moberg CA, Hachiya LY, Curtin JJ 2013. Alcohol stress response dampening during imminent versus distal, uncertain threat. J. Abnorm. Psychol. 122:3756–69 https://doi.org/10.1037/a0033407
    [Crossref] [Google Scholar]
  62. Hefner KR, Starr MJ, Curtin JJ 2018. Heavy marijuana use but not deprivation is associated with increased stressor reactivity. J. Abnorm. Psychol. 127:4348–58 https://doi.org/10.1037/abn0000344
    [Crossref] [Google Scholar]
  63. Heilig M, Epstein DH, Nader MA, Shaham Y 2016. Time to connect: bringing social context into addiction neuroscience. Nat. Rev. Neurosci. 17:9592–99 https://doi.org/10.1038/nrn.2016.67
    [Crossref] [Google Scholar]
  64. Hogle JM, Curtin JJ. 2006. Sex differences in negative affective response during nicotine withdrawal. Psychophysiology 43:4344–56 https://doi.org/10.1111/j.1469-8986.2006.00406.x
    [Crossref] [Google Scholar]
  65. Hogle JM, Kaye JT, Curtin JJ 2010. Nicotine withdrawal increases threat-induced anxiety but not fear: neuroadaptation in human addiction. Biol. Psychiatry 68:8687–88 https://doi.org/10.1016/j.biopsych.2010.06.003
    [Crossref] [Google Scholar]
  66. Jansma A, Breteler MH, Schippers GM, de Jong CA, Van Der Staak CF 2000. No effect of negative mood on the alcohol cue reactivity of in-patient alcoholics. Addict. Behav. 25:4619–24
     [Google Scholar]
  67. Jobes ML, Ghitza UE, Epstein DH, Phillips KA, Heishman SJ, Preston KL 2011. Clonidine blocks stress-induced craving in cocaine users. Psychopharmacology 218:183–88 https://doi.org/10.1007/s00213-011-2230-7
    [Crossref] [Google Scholar]
  68. Kabat-Zinn J. 2005. Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain, and Illness New York: Delta Trade Paperb, 15th anniv. ed..
  69. Kaye JT, Bradford DE, Magruder KP, Curtin JJ 2017. Probing for neuroadaptations to unpredictable stressors in addiction: translational methods and emerging evidence. J. Stud. Alcohol Drugs 78:3353–71 https://doi.org/10.15288/jsad.2017.78.353 Synthesizes preclinical and clinical research to highlight the role of stressor predictability in CNS stress allostasis.
     [Crossref] [Google Scholar]
  70. Kaye JT, Fronk GE, Zgierska AE, Cruz MR, Rabago D, Curtin JJ 2019. Acute prazosin administration does not reduce stressor reactivity in healthy adults. Psychopharmacology 236:3371–82 https://doi.org/10.1007/s00213-019-05297-x
    [Crossref] [Google Scholar]
  71. Kenna GA, Haass-Koffler CL, Zywiak WH, Edwards SM, Brickley MB et al. 2016. Role of the α1 blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial. Addict. Biol. 21:4904–14 https://doi.org/10.1111/adb.12275
    [Crossref] [Google Scholar]
  72. Khantzian EJ. 1997. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv. Rev. Psychiatry 4:5231–44 https://doi.org/10.3109/10673229709030550
    [Crossref] [Google Scholar]
  73. Kheirabadi GR, Ranjkesh M, Maracy MR, Salehi M 2008. Effect of add-on gabapentin on opioid withdrawal symptoms in opium-dependent patients. Addiction 103:91495–99 https://doi.org/10.1111/j.1360-0443.2008.02248.x
    [Crossref] [Google Scholar]
  74. Kiluk BD, Carroll KM. 2013. New developments in behavioral treatments for substance use disorders. Curr. Psychiatry Rep. 15:12420 https://doi.org/10.1007/s11920-013-0420-1
    [Crossref] [Google Scholar]
  75. Kober H, Brewer JA, Height KL, Sinha R 2017. Neural stress reactivity relates to smoking outcomes and differentiates between mindfulness and cognitive-behavioral treatments. Neuroimage 151:4–13 https://doi.org/10.1016/j.neuroimage.2016.09.042
    [Crossref] [Google Scholar]
  76. Koob GF. 2015. The dark side of emotion: the addiction perspective. Eur. J. Pharmacol. 753:73–87 https://doi.org/10.1016/j.ejphar.2014.11.044
    [Crossref] [Google Scholar]
  77. Koob GF, Le Moal M 2008. Addiction and the brain antireward system. Annu. Rev. Psychol. 59:29–53 https://doi.org/10.1146/annurev.psych.59.103006.093548 Discusses neurobiological stress mechanisms explicitly in substance use disorders.
     [Crossref] [Google Scholar]
  78. Koob GF, Zorrilla EP. 2010. Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor. Curr. Opin. Investig. Drugs 11:163–71
     [Google Scholar]
  79. Kranzler HR, Feinn R, Morris P, Hartwell EE 2019. A meta-analysis of the efficacy of gabapentin for treating alcohol use disorder. Addiction 114:91547–55 https://doi.org/10.1111/add.14655
    [Crossref] [Google Scholar]
  80. Ksobiech K. 2003. A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. AIDS Educ. Prev. 15:3257–68
     [Google Scholar]
  81. Kwako LE, Spagnolo PA, Schwandt ML, Thorsell A, George DT et al. 2015. The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study. Neuropsychopharmacology 40:51053–63 https://doi.org/10.1038/npp.2014.306
    [Crossref] [Google Scholar]
  82. Lane R, Waldstein S, Chesney M, Jennings J, Lovallo W et al. 2009. The rebirth of neuroscience in psychosomatic medicine, part I: historical context, methods, and relevant basic science. Psychosom. Med. 71:2117–34 https://doi.org/10.1097/PSY.0b013e31819783be
    [Crossref] [Google Scholar]
  83. Lazarus RS. 1966. Psychological Stress and the Coping Process New York: McGraw-Hill
  84. Lazarus RS. 1999. Stress and Emotion: A New Synthesis New York: Springer
  85. Leventhal AM, Zvolensky MJ. 2015. Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion–smoking comorbidity. Psychol. Bull. 141:1176–212 https://doi.org/10.1037/bul0000003
    [Crossref] [Google Scholar]
  86. Li W, Howard MO, Garland EL, McGovern P, Lazar M 2017. Mindfulness treatment for substance misuse: a systematic review and meta-analysis. J. Subst. Abuse Treat. 75:62–96 https://doi.org/10.1016/j.jsat.2017.01.008
    [Crossref] [Google Scholar]
  87. Magill M, Kiluk BD, McCrady BS, Tonigan JS, Longabaugh R 2015. Active ingredients of treatment and client mechanisms of change in behavioral treatments for alcohol use disorders: progress 10 years later. Alcohol Clin. Exp. Res. 39:101852–62 https://doi.org/10.1111/acer.12848
    [Crossref] [Google Scholar]
  88. Magill M, Ray LA. 2009. Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J. Stud. Alcohol Drugs 70:4516–27 https://doi.org/10.15288/jsad.2009.70.516
    [Crossref] [Google Scholar]
  89. Maier SF, Seligman MEP. 2016. Learned helplessness at fifty: insights from neuroscience. Psychol. Rev. 123:4349–67 https://doi.org/10.1037/rev0000033
    [Crossref] [Google Scholar]
  90. Mantsch JR, Baker DA, Francis DM, Katz ES, Hoks MA, Serge JP 2008. Stressor- and corticotropin releasing factor-induced reinstatement and active stress-related behavioral responses are augmented following long-access cocaine self-administration by rats. Psychopharmacology 195:4591–603 https://doi.org/10.1007/s00213-007-0950-5
    [Crossref] [Google Scholar]
  91. Mantsch JR, Baker DA, Funk D, Lê AD, Shaham Y 2016. Stress-induced reinstatement of drug seeking: 20 years of progress. Neuropsychopharmacology 41:1335–56 https://doi.org/10.1038/npp.2015.142 Reviews robust evidence for stressor-induced reinstatement of drug-seeking behavior in rodents.
     [Crossref] [Google Scholar]
  92. Mason BJ, Crean R, Goodell V, Light JM, Quello S et al. 2012. A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults. Neuropsychopharmacology 37:71689–98 https://doi.org/10.1038/npp.2012.14
    [Crossref] [Google Scholar]
  93. Mason BJ, Light JM, Escher T, Drobes DJ 2008. Effect of positive and negative affective stimuli and beverage cues on measures of craving in non treatment-seeking alcoholics. Psychopharmacology 200:1141–50 https://doi.org/10.1007/s00213-008-1192-x
    [Crossref] [Google Scholar]
  94. Mason BJ, Quello S, Shadan F 2018. Gabapentin for the treatment of alcohol use disorder. Expert Opin. Investig. Drugs 27:1113–24 https://doi.org/10.1080/13543784.2018.1417383
    [Crossref] [Google Scholar]
  95. Mason JW. 1975. A historical view of the stress field. J. Hum. Stress 1:222–36 https://doi.org/10.1080/0097840X.1975.9940405
    [Crossref] [Google Scholar]
  96. McCarthy DE, Piasecki TM, Fiore MC, Baker TB 2006. Life before and after quitting smoking: an electronic diary study. J. Abnorm. Psychol. 115:3454–66 https://doi.org/10.1037/0021-843X.115.3.454
    [Crossref] [Google Scholar]
  97. McEwen BS. 2017. Allostasis and the epigenetics of brain and body health over the life course: the brain on stress. JAMA Psychiatry 74:6551–52 https://doi.org/10.1001/jamapsychiatry.2017.0270 Positions the brain as the central organ of stress allostasis and discusses psychological and physiological interaction during adaptation.
     [Crossref] [Google Scholar]
  98. McEwen BS, Gianaros PJ. 2011. Stress- and allostasis-induced brain plasticity. Annu. Rev. Med. 62:431–45 https://doi.org/10.1146/annurev-med-052209-100430
    [Crossref] [Google Scholar]
  99. McEwen BS, Wingfield JC. 2010. What's in a name? Integrating homeostasis, allostasis and stress. Horm. Behav. 57:2105–111 https://doi.org/10.1016/j.yhbeh.2009.09.011
    [Crossref] [Google Scholar]
  100. McKee SA, Potenza MN, Kober H, Sofuoglu M, Arnsten AFT et al. 2015. A translational investigation targeting stress-reactivity and prefrontal cognitive control with guanfacine for smoking cessation. J. Psychopharmacol. 29:3300–11 https://doi.org/10.1177/0269881114562091
    [Crossref] [Google Scholar]
  101. Moberg CA, Bradford DE, Kaye JT, Curtin JJ 2017. Increased startle potentiation to unpredictable stressors in alcohol dependence: possible stress neuroadaptation in humans. J. Abnorm. Psychol. 126:4441–53 https://doi.org/10.1037/abn0000265
    [Crossref] [Google Scholar]
  102. Moberg CA, Weber S, Curtin JJ 2011. Alcohol dose effects on stress response to cued threat vary by threat intensity. Psychopharmacology 218:217–27
     [Google Scholar]
  103. Moran LM, Kowalczyk WJ, Phillips KA, Vahabzadeh M, Lin J-L et al. 2018. Sex differences in daily life stress and craving in opioid-dependent patients. Am. J. Drug Alcohol Abuse 44:5512–23 https://doi.org/10.1080/00952990.2018.1454934
    [Crossref] [Google Scholar]
  104. Myrick H, Henderson S, Malcolm R 2001. Gabapentin in the treatment of cocaine dependence: a case series. J. Clin. Psychiatry 62:119–23
     [Google Scholar]
  105. Nakajima M, Al'Absi M. 2014. Nicotine withdrawal and stress-induced changes in pain sensitivity: a cross-sectional investigation between abstinent smokers and nonsmokers. Psychophysiology 51:101015–22 https://doi.org/10.1111/psyp.12241
    [Crossref] [Google Scholar]
  106. Neupert SD, Desmarais SL, Gray JS, Cohn AM, Doherty S, Knight K 2017. Daily stressors as antecedents, correlates, and consequences of alcohol and drug use and cravings in community-based offenders. Psychol. Addict. Behav. 31:3315–25 https://doi.org/10.1037/adb0000276
    [Crossref] [Google Scholar]
  107. Newman S, Goldman H. 2008. Putting housing first, making housing last: housing policy for persons with severe mental illness. Am. J. Psychiatry 165:101242–48 https://doi.org/10.1176/appi.ajp.2008.08020279
    [Crossref] [Google Scholar]
  108. O'Dell LE, Roberts AJ, Smith RT, Koob GF 2004. Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure. Alcohol. Clin. Exp. Res. 28:111676–82 https://doi.org/10.1097/01.ALC.0000145781.11923.4E
    [Crossref] [Google Scholar]
  109. Peckham AM, Evoy KE, Ochs L, Covvey JR 2018. Gabapentin for off-label use: evidence-based or cause for concern. Subst. Abuse 12: https://doi.org/10.1177/1178221818801311
    [Crossref] [Google Scholar]
  110. Petrakis IL, Desai N, Gueorguieva R, Arias A, O'Brien E et al. 2016. Prazosin for veterans with posttraumatic stress disorder and comorbid alcohol dependence: a clinical trial. Alcohol Clin. Exp. Res. 40:1178–86 https://doi.org/10.1111/acer.12926
    [Crossref] [Google Scholar]
  111. Phillips AC, Der G, Hunt K, Carroll D 2009. Haemodynamic reactions to acute psychological stress and smoking status in a large community sample. Int. J. Psychophysiol. 73:3273–78 https://doi.org/10.1016/j.ijpsycho.2009.04.005
    [Crossref] [Google Scholar]
  112. Piper ME, Curtin JJ. 2006. Tobacco withdrawal and negative affect: an analysis of initial emotional response intensity and voluntary emotion regulation. J. Abnorm. Psychol. 115:196–102 https://doi.org/10.1037/0021-843X.115.1.96
    [Crossref] [Google Scholar]
  113. Pratt WM, Davidson D. 2009. Role of the HPA axis and the A118G polymorphism of the mu-opioid receptor in stress-induced drinking behavior. Alcohol Alcohol 44:4358–65 https://doi.org/10.1093/alcalc/agp007
    [Crossref] [Google Scholar]
  114. Preston KL, Kowalczyk WJ, Phillips KA, Jobes ML, Vahabzadeh M et al. 2017. Context and craving during stressful events in the daily lives of drug-dependent patients. Psychopharmacology 234:172631–42 https://doi.org/10.1007/s00213-017-4663-0
    [Crossref] [Google Scholar]
  115. Preston KL, Kowalczyk WJ, Phillips KA, Jobes ML, Vahabzadeh M et al. 2018a. Before and after: craving, mood, and background stress in the hours surrounding drug use and stressful events in patients with opioid-use disorder. Psychopharmacology 235:92713–23 https://doi.org/10.1007/s00213-018-4966-9
    [Crossref] [Google Scholar]
  116. Preston KL, Schroeder JR, Kowalczyk WJ, Phillips KA, Jobes ML et al. 2018b. End-of-day reports of daily hassles and stress in men and women with opioid-use disorder: relationship to momentary reports of opioid and cocaine use and stress. Drug Alcohol Depend 193:21–28 https://doi.org/10.1016/j.drugalcdep.2018.08.023
    [Crossref] [Google Scholar]
  117. Raby WN, Coomaraswamy S. 2004. Gabapentin reduces cocaine use among addicts from a community clinic sample. J. Clin. Psychiatry 65:184–86
     [Google Scholar]
  118. Ray LA. 2011. Stress-induced and cue-induced craving for alcohol in heavy drinkers: preliminary evidence of genetic moderation by the OPRM1 and CRH-BP genes. Alcohol Clin. Exp. Res. 35:1166–74 https://doi.org/10.1111/j.1530-0277.2010.01333.x
    [Crossref] [Google Scholar]
  119. Roberto M, Gilpin NW, O'Dell LE, Cruz MT, Morse AC et al. 2008. Cellular and behavioral interactions of gabapentin with alcohol dependence. J. Neurosci. 28:225762–71 https://doi.org/10.1523/JNEUROSCI.0575-08.2008
    [Crossref] [Google Scholar]
  120. Salehi M, Kheirabadi GR, Maracy MR, Ranjkesh M 2011. Importance of gabapentin dose in treatment of opioid withdrawal. J. Clin. Psychopharmacol. 31:5593–96 https://doi.org/10.1097/JCP.0b013e31822bb378
    [Crossref] [Google Scholar]
  121. Sapolsky RM. 2015. Stress and the brain: individual variability and the inverted-U. Nat. Neurosci. 18:101344–46 https://doi.org/10.1038/nn.4109 Highlights individual variability in the inverted-U curve of stress effects as the most important concept in the stress field.
     [Crossref] [Google Scholar]
  122. Sayette MA. 1993. An appraisal-disruption model of alcohol's effects on stress responses in social drinkers. Psychol. Bull. 114:3459–76
     [Google Scholar]
  123. Schmitz A, Grillon C. 2012. Assessing fear and anxiety in humans using the threat of predictable and unpredictable aversive events (the NPU-threat test). Nat. Protoc. 7:3527–32 https://doi.org/10.1038/nprot.2012.001
    [Crossref] [Google Scholar]
  124. Schwandt ML, Cortes CR, Kwako LE, George DT, Momenan R et al. 2016. The CRF1 antagonist verucerfont in anxious alcohol-dependent women: translation of neuroendocrine, but not of anti-craving effects. Neuropsychopharmacology 41:2818–29 https://doi.org/10.1038/npp.2016.61
    [Crossref] [Google Scholar]
  125. Segal ZV, Williams JMG, Teasdale JD, Kabat-Zinn J 2012. Mindfulness-Based Cognitive Therapy for Depression New York: Guilford, 2nd ed..
  126. Segerstrom SC, Miller GE. 2004. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull. 130:4601–30 https://doi.org/10.1037/0033-2909.130.4.601
    [Crossref] [Google Scholar]
  127. Selye H. 1936. A syndrome produced by diverse nocuous agents. Nature 138:32 https://doi.org/10.1038/138032a0
    [Crossref] [Google Scholar]
  128. Selye H. 1975. Confusion and controversy in the stress field. J. Hum. Stress 1:237–44
     [Google Scholar]
  129. Serre F, Fatseas M, Denis C, Swendsen J, Auriacombe M 2018. Predictors of craving and substance use among patients with alcohol, tobacco, cannabis or opiate addictions: commonalities and specificities across substances. Addict. Behav. 83:123–29 https://doi.org/10.1016/j.addbeh.2018.01.041
    [Crossref] [Google Scholar]
  130. Shaham Y, de Wit H 2016. Lost in translation: CRF1 receptor antagonists and addiction treatment. Neuropsychopharmacology 41:122795–97 https://doi.org/10.1038/npp.2016.94
    [Crossref] [Google Scholar]
  131. Sheffield D, Smith GD, Carroll D, Shipley MJ, Marmot MG 1997. The effects of recent food, alcohol, and tobacco intake and the temporal scheduling of testing on cardiovascular activity at rest and during psychological stress. Psychophysiology 34:2204–12 https://doi.org/10.1111/j.1469-8986.1997.tb02133.x
    [Crossref] [Google Scholar]
  132. Sher KJ. 1987. Stress response dampening. Psychological Theories of Drinking and Alcoholism HT Blane, KE Leonard 227–71 New York: Guilford
     [Google Scholar]
  133. Shiffman S, Waters AJ. 2004. Negative affect and smoking lapses: a prospective analysis. J. Consult. Clin. Psychol. 72:2192–201 https://doi.org/10.1037/0022-006X.72.2.192
    [Crossref] [Google Scholar]
  134. Simpson TL, Saxon A, Meredith C, Malte C, McBride B et al. 2009. A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence. Alcohol. Clin. Exp. Res. 33:2255–63 https://doi.org/10.1111/j.1530-0277.2008.00807.x
    [Crossref] [Google Scholar]
  135. Simpson TL, Saxon AJ, Stappenbeck C, Malte CA, Lyons R et al. 2018. Double-blind randomized clinical trial of prazosin for alcohol use disorder. Am. J. Psychiatry 175:121216–24 https://doi.org/10.1176/appi.ajp.2018.17080913
    [Crossref] [Google Scholar]
  136. Sinha R. 2009. Modeling stress and drug craving in the laboratory: implications for addiction treatment development. Addict. Biol. 14:184–98 https://doi.org/10.1111/j.1369-1600.2008.00134.x
    [Crossref] [Google Scholar]
  137. Sinha R, Fox HC, Hong KA, Bergquist K, Bhagwagar Z, Siedlarz KM 2009. Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals. Neuropsychopharmacology 34:51198–208 https://doi.org/10.1038/npp.2008.78
    [Crossref] [Google Scholar]
  138. Sinha R, Fox HC, Hong K-IA, Hansen J, Tuit K, Kreek MJ 2011. Effects of adrenal sensitivity, stress- and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes. Arch. Gen. Psychiatry 68:9942–52 https://doi.org/10.1001/archgenpsychiatry.2011.49
    [Crossref] [Google Scholar]
  139. Sinha R, Garcia M, Paliwal P, Kreek MJ, Rounsaville BJ 2006. Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch. Gen. Psychiatry 63:3324–31 https://doi.org/10.1001/archpsyc.63.3.324
    [Crossref] [Google Scholar]
  140. Sinha R, Kimmerling A, Doebrick C, Kosten T 2007. Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings. Psychopharmacology 190:4569–74 https://doi.org/10.1007/s00213-006-0640-8
    [Crossref] [Google Scholar]
  141. Sinha R, Talih M, Malison R, Cooney N, Anderson GM, Kreek MJ 2003. Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology 170:162–72 https://doi.org/10.1007/s00213-003-1525-8
    [Crossref] [Google Scholar]
  142. Smith R, Aston-Jones G. 2008. Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct. Funct. 213:1–243–61 https://doi.org/10.1007/s00429-008-0191-3
    [Crossref] [Google Scholar]
  143. Stopponi S, Somaini L, Cippitelli A, de Guglielmo G, Kallupi M et al. 2012. Pregabalin reduces alcohol drinking and relapse to alcohol seeking in the rat. Psychopharmacology 220:187–96 https://doi.org/10.1007/s00213-011-2457-3
    [Crossref] [Google Scholar]
  144. Tackett JL, Brandes CM, King KM, Markon KE 2019. Psychology's replication crisis and clinical psychological science. Annu. Rev. Clin. Psychol. 15:579–604 https://doi.org/10.1146/annurev-clinpsy-050718-095710
    [Crossref] [Google Scholar]
  145. Tang Y-Y, Tang R, Posner MI 2016. Mindfulness meditation improves emotion regulation and reduces drug abuse. Drug Alcohol Depend 163:Suppl. 1S13–18 https://doi.org/10.1016/j.drugalcdep.2015.11.041
    [Crossref] [Google Scholar]
  146. Tapper K. 2018. Mindfulness and craving: effects and mechanisms. Clin. Psychol. Rev. 59:101–17 https://doi.org/10.1016/j.cpr.2017.11.003
    [Crossref] [Google Scholar]
  147. Vanderkaay MM, Patterson SM. 2006. Nicotine and acute stress: effects of nicotine versus nicotine withdrawal on stress-induced hemoconcentration and cardiovascular reactivity. Biol. Psychol. 71:2191–201 https://doi.org/10.1016/j.biopsycho.2005.04.006
    [Crossref] [Google Scholar]
  148. Verplaetse TL, Weinberger AH, Oberleitner LM, Smith KM, Pittman BP et al. 2017. Effect of doxazosin on stress reactivity and the ability to resist smoking. J. Psychopharmacol. 31:7830–40 https://doi.org/10.1177/0269881117699603
    [Crossref] [Google Scholar]
  149. Verplaetse TL, Weinberger AH, Smith PH, Cosgrove KP, Mineur YS et al. 2015. Targeting the noradrenergic system for gender-sensitive medication development for tobacco dependence. Nicotine Tob. Res. 17:4486–95 https://doi.org/10.1093/ntr/ntu280
    [Crossref] [Google Scholar]
  150. Villano WJ, Ezie CEC, Gillis R, Otto AR, Heller AS 2020. Temporal dynamics of real-world emotion are more strongly linked to prediction error than outcome. J. Exp. Psychol. Gen. https://doi.org/10.1037/xge0000740
    [Crossref] [Google Scholar]
  151. Volz AR, Dennis PA, Dennis MF, Calhoun PS, Wilson SM, Beckham JC 2014. The role of daily hassles and distress tolerance in predicting cigarette craving during a quit attempt. Nicotine Tob. Res. 16:6872–75 https://doi.org/10.1093/ntr/ntt286
    [Crossref] [Google Scholar]
  152. Ward MM, Swan GE, Jack LM, Javitz HS 1994. Effect of smoking cessation and relapse on cardiovascular levels and reactivity. Psychopharmacology 114:1147–54
     [Google Scholar]
  153. Weiss JM. 1972. Psychological factors in stress and disease. Scientific American 226:6104–13
     [Google Scholar]
  154. Wemm SE, Sinha R. 2019. Drug-induced stress responses and addiction risk and relapse. Neurobiol. Stress 10:100148 https://doi.org/10.1016/j.ynstr.2019.100148
    [Crossref] [Google Scholar]
  155. Wielgosz J, Goldberg SB, Kral TRA, Dunne JD, Davidson RJ 2019. Mindfulness meditation and psychopathology. Annu. Rev. Clin. Psychol. 15:285–316 https://doi.org/10.1146/annurev-clinpsy-021815-093423
    [Crossref] [Google Scholar]
  156. Witkiewitz K, Bowen S, Harrop EN, Douglas H, Enkema M, Sedgwick C 2014. Mindfulness-based treatment to prevent addictive behavior relapse: theoretical models and hypothesized mechanisms of change. Subst. Use Misuse 49:5513–24 https://doi.org/10.3109/10826084.2014.891845
    [Crossref] [Google Scholar]
  157. Witkiewitz K, Lustyk MKB, Bowen S 2013. Retraining the addicted brain: a review of hypothesized neurobiological mechanisms of mindfulness-based relapse prevention. Psychol. Addict. Behav. 27:2351–65 https://doi.org/10.1037/a0029258
    [Crossref] [Google Scholar]
  158. Zvolensky MJ, Vujanovic AA, Bernstein A, Leyro T 2010. Distress tolerance. Curr. Dir. Psychol. Sci. 19:6406–10 https://doi.org/10.1177/0963721410388642
    [Crossref] [Google Scholar]
  159. Zvolensky MJ, Yartz AR, Gregor K, Gonzalez A, Bernstein A et al. 2008. Interoceptive exposure-based cessation intervention for smokers high in anxiety sensitivity: a case series. J. Cogn. Psychother. 22:4346–65 https://doi.org/10.1891/0889-8391.22.4.346
    [Crossref] [Google Scholar]
/content/journals/10.1146/annurev-clinpsy-102419-125016
Loading
Stress Allostasis in Substance Use Disorders: Promise, Progress, and Emerging Priorities in Clinical Research
Annual Review of Clinical Psychology 16, 401 (2020); https://doi.org/10.1146/annurev-clinpsy-102419-125016
/content/journals/10.1146/annurev-clinpsy-102419-125016
/content/journals/10.1146/annurev-clinpsy-102419-125016
Loading

Data & Media loading...

Supplemental Material

Supplementary Data

  • Article Type: Review Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error